Miguel Sieler - Neovacs
Neovacs, a French biotechnology company focused on the development of Kinoids, has hired former CEO of Bayer France Miguel Sieler as its own CEO.
"Miguel Sieler will build on the work of Guy-Charles Fanneau De La Horie to make Neovacs a leading company in the field of therapeutic vaccines and increase the Company’s value" said Jean-Jacques Bertrand, Chairman of Neovacs. He added: "We thank Guy-Charles who has built with success a strong technologic platform and has led into phase II very promising products targeting significant markets."